1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Growing evidence indicates that alterations within the peripheral nervous system (PNS) are involved at an early stage in the amyotrophic lateral sclerosis (ALS) pathogenetic cascade. In this study, magnetic resonance imaging (MRI), neurophysiologic analyses, and histologic analyses were used to monitor the extent of PNS damage in the hSOD-1 ALS rat model. The imaging signature of the disease was defined using in vivo MRI of the sciatic nerve. Initial abnormalities were detected in the nerves by an increase in T2 relaxation time before the onset of clinical disease; diffusion MRI showed a progressive increase in mean and radial diffusivity and reduction of fractional anisotropy at advanced stages of disease. Histologic analysis demonstrated early impairment of the blood-nerve barrier followed by acute axonal degeneration associated with endoneurial edema and macrophage response in motor nerve compartments. Progressive axonal degeneration and motor nerve fiber loss correlated with MRI and neurophysiologic changes. These functional and morphologic investigations of the PNS might be applied in following disease progression in preclinical therapeutic studies. This study establishes the PNS signature in this rat ALS model (shedding new light into pathogenesis) and provides a rationale for translating into future systematic MRI studies of PNS involvement in patients with ALS.

          Related collections

          Author and article information

          Journal
          J Neuropathol Exp Neurol
          Journal of neuropathology and experimental neurology
          Ovid Technologies (Wolters Kluwer Health)
          1554-6578
          0022-3069
          Jul 2014
          : 73
          : 7
          Affiliations
          [1 ] From the Neuropathology Unit, Institute of Experimental Neurology (NR, LC, TD, GD, FC, GC, AQ) and Division of Neuroscience (NR, LC, DU, FB, FC, PP, UDC, GC, AQ), IRCCS San Raffaele Scientific Institute; Laboratory of Molecular Neurobiology, Department of Neuroscience, IRCCS Istituto di Ricerche Farmacologiche Mario Negri (MP, GS, CB); Department of Neurorehabilitation Sciences, Casa Cura Policlinico (MC); and Vita e Salute San Raffaele University (GC), Milan, Italy.
          Article
          10.1097/NEN.0000000000000081
          24918640
          a5db39bd-e32a-47ed-8d68-2ea9b514df25
          History

          Comments

          Comment on this article